Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=29849592
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
The Value of Fecal Microbiota Transplantation in the Treatment of Ulcerative
Colitis Patients: A Systematic Review and Meta-Analysis
#MMPMID29849592
Cao Y
; Zhang B
; Wu Y
; Wang Q
; Wang J
; Shen F
Gastroenterol Res Pract
2018[]; 2018
(?): 5480961
PMID29849592
show ga
BACKGROUND AND AIMS: Fecal microbiota transplantation (FMT) has challenged the
traditional management of ulcerative colitis (UC) in recent years, while it
remained controversial. We aimed to provide a systematic protocol of FMT
treatment on UC. METHODS: Studies reporting on FMT treatment in UC patients were
performed. A fixed-effect model was used to assess the efficacy of FMT. RESULTS:
Eighteen studies were enrolled (n = 446). A pooled proportion of patients who
received FMT had a significant efficacy compared to the placebo group (odds ratio
(OR): 2.73, P = 0.002) with a low risk of heterogeneity (P = 0.59, I(2) = 0%).
The Mayo score decreased to 5 points in a state of mild-moderate activity after
FMT treatment, and the optimal range of the Mayo score baseline was 6-9 for FMT
administration. Then, the baseline of the Shannon diversity index (SDI) had a
negative correlation with the clinical response rate (R = -0.992, P = 0.08) or
remission rate (R = -0.998, P = 0.036), and the optimal diversity of bacteria was
at 7 days to one month. Moreover, the colonoscopy delivery and unrelated fecal
donor had slight superiorities of FMT treatment. CONCLUSION: FMT treatment had a
higher efficacy and shorter time-point of early assessment of effectiveness on UC
patients compared to traditional therapies. And the optimal FMT delivery and
donor were colonoscopy delivery and unrelated donor in clinical practice.
free
free
free
